Synthesis and biological evaluation of DIDS analogues as efficient inhibitors of RAD51 involved in homologous

Alexandre Demeyer1, Lucie Fonteneau1, Marion Liennard2

  • 1Nantes Université, CNRS, US2B, UMR 6286, DNA-repair Group, F-44000 Nantes, France.

Insights

Researchers developed novel RAD51 inhibitors based on the DIDS molecule. These compounds show potential for enhancing cancer treatment efficacy by targeting homologous recombination DNA repair in cancer cells.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Medicinal Chemistry

Background:

  • RAD51 protein is crucial for homologous recombination DNA repair.
  • Overexpression of RAD51 in cancer cells can reduce sensitivity to chemotherapy and radiotherapy.
  • Targeting RAD51 offers a strategy to re-sensitize cancer cells to existing treatments.

Purpose of the Study:

  • To develop novel RAD51 inhibitors.
  • To investigate structure-activity relationships of DIDS analogues as RAD51 inhibitors.
  • To identify potent RAD51 inhibitors for potential cancer therapy.

Main Methods:

  • Synthesis of two series of 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS) analogues with varying substituents.
  • Structure-activity relationship (SAR) studies.
  • Assay of RAD51 inhibitory activity and homologous recombination (HR) inhibition.

Main Results:

  • Several DIDS analogues were synthesized and evaluated for RAD51 inhibitory potential.
  • Three compounds, including cyano (12), benzamide (23), and phenylcarbamate (29) analogues, demonstrated potent RAD51 inhibition.
  • These novel inhibitors exhibited homologous recombination inhibition in the micromolar range.

Conclusions:

  • The synthesized DIDS analogues represent a new class of potent RAD51 inhibitors.
  • These compounds hold promise for restoring cancer cell sensitivity to radio- and chemotherapy.
  • Further development of these inhibitors could lead to improved cancer treatment strategies.

Related Concept Videos

Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.8K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
6.1K
Diels–Alder Reaction: Characteristics of Dienes01:29

Diels–Alder Reaction: Characteristics of Dienes

The Diels–Alder reaction brings together a diene and a dienophile to form a six-membered ring. Both components have unique characteristics that influence the rate of the reaction.
Characteristics of the diene
Conformation
The simplest example of a diene is 1,3-butadiene, an acyclic conjugated π system. At room temperature, the molecule exists as a mixture of s-cis and s-trans conformers by virtue of rotation around the carbon–carbon single bond. Although the s-trans isomer is...
4.2K